SEC Tracker
Get the app

Obalon Therapeutics HIND

Obalon Therapeutics: quarterly report (amended) for the quarter ended Mar 31, 2020

Form
10-Q/A
Filed
Period
Importance
Routine
Document
10-Q/A

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Obalon Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. AIM ImmunoTech AIM public float $6M, Jun 30, 2025
  2. Adial Pharmaceuticals ADIL public float $6M, Jun 30, 2025
  3. PharmaCyte Biotech PMCB public float $6M, Oct 31, 2025
  4. Natural Alternatives International NAII public float $6M, Dec 31, 2025
  5. LFTD Partners LIFD public float $6M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.